SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001654954-24-001703
Filing Date
2024-02-14
Accepted
2024-02-14 08:24:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT CamberMYGN13Ga2024.htm SC 13G/A 63264
2 JOINT FILLING AGREEMENT CamberMYGN-13Ga2024ex1.htm EX-1 5552
  Complete submission text file 0001654954-24-001703.txt   70504
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 24632545
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LP (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A